Abstract:Shang Cai 1 , Qingqing Chen 2 , Yingying Xu 1 , Qianfeng Zhuang 3 , Shengjun Ji 2 1 Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China; 2 Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China; 3 Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China Submitted Jul 29, 2024. Accepted for publication Sep 10, 2024. Published online Oct 21, 2024. doi: 10.21037/tcr-2024-6 Retraction to: Transl Cancer Res 2020;9:1439-47. The article (1) "Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling" (doi: 10.21037/tcr.2020.01.27) published in the Vol 9, No 3 (March 31, 2020) issue of Translational Cancer Research has been retracted at the request of all the authors. During a comprehensive review of the experimental data and accompanying figures, an unintentional error was identified in the duplication of certain panels within Figure 7A , attributed to a lapse during the assembly of the visual materials. This mistake does not affect the interpretation or conclusion of this article, as the relevant experiments were repeated, and replaceable figures from these repeated experiments can be found. Nonetheless, the authors have decided to retract this article considering the rigor and accuracy required in scientific research. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2024-6/coif). The authors have no conflicts of interest to declare. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

RETRACTION: Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activated protein kinase signalling pathway (Retraction of Vol 33, Pg 840, 2015)

Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Retraction: Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy

Retraction: Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis

RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway

Retraction Note: STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‐152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway

Retracted: Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling

RETRACTED: Physcion 8-O-β-glucopyranoside Inhibits Clear-Cell Renal Cell Carcinoma Bydownregulating Hexokinase II and Inhibiting Glycolysis.

Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Retraction: ANGPTL1 Interacts with Integrin Α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction]

RETRACTION: Propofol-Induced miR-219-5p Inhibits Growth and Invasion of Hepatocellular Carcinoma Through Suppression of GPC3-Mediated Wnt/β-Catenin Signalling Activation

Retracted: Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1α and Increased Levels of Reactive Oxygen Species

RETRACTED:Inhibition of KRAS Gene Mutation on Non-Small Cell Lung Cancer and Its Effect on Circulating Tumor Cells

Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K/AKT Pathway

RETRACTION: "Effect of PLK1 Inhibition on Cisplatin-resistant Gastric Cancer Cells"